search
Back to results

Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation (3T-CO)

Primary Purpose

Chronic Obstipation

Status
Unknown status
Phase
Phase 3
Locations
Germany
Study Type
Interventional
Intervention
Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation
EMG-biofeedback alone
Sponsored by
dr. schwandner
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstipation focused on measuring Exercise Therapy, Biofeedback (Psychology), Adult, Chronic Obstipation/*therapy, EMG - Biofeedback, EMG - Triggered Stimulation, Augmented biofeedback

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All Patients with chronic obstipation (Rom criteria II)

Exclusion Criteria:

  • Chronic inflammatory bowel disease, systemic peripheral neuropathy (MS, diabetes), disorders of enteric nervous system (Hirschsprung disease, chagas, IND, myopathy desmosis coli), idiopathic megacolon/megarectum, patients with mental or intellectual deficits.

Sites / Locations

  • University of Gießen, Dept. of General SurgeryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Triple Target Treatment

EMG-biofeedback alone

Arm Description

In the 3T arm, patients were stimulated with a carrier wave of 25 KHz and biphasic modulations of the pulse train of 40 Hz. Anxious patients trained at first only in the biofeedback mode. The stimulation was introduced after four weeks for these patients. Patients were instructed to carry out the training at home, with an alternating combination in the morning and with EMG-triggered stimulation in the evening, each for 20-minute periods. Apart from this, the protocol of the active treatment group was identical to that of the control group.

In the biofeedback arm, patients were instructed to carry out EMG-biofeedback training at home, standing, mornings and evenings, for 20-minute periods. The core of the task was to pull the plug-electrode upward inside the anal channel, like a lift, and to hold it there during varying periods of tension. This can only be done successfully if the perineum rises and at the same time the puborectal muscle is activated. Just squeezing the sphincter muscles does not produce this lifting effect.

Outcomes

Primary Outcome Measures

Altomare ODS Score in its validated form after 3 and 12 months, compared to baseline.

Secondary Outcome Measures

Constipation severity instrument (CSI) in adapted German form after 3 and 12 months, compared to baseline.
Modified Wexner Incontinence Score after 3 and 12 months, compared to baseline
Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QoL) after 3 and 12 months compared to baseline, as well as between the two treatment groups over the course of time as compared to baseline.
Hinton Test after 3 and 12 months
Cleveland Clinic Incontinence Score (CCS) in its validated German form after 3 and 12 months, compared to baseline
Adapted Vaizey score after 3 and 12 months compared to baseline
International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) applied to patients with urine incontinence after 3 and 12 months, compared to baseline.

Full Information

First Posted
August 7, 2012
Last Updated
September 20, 2013
Sponsor
dr. schwandner
search

1. Study Identification

Unique Protocol Identification Number
NCT01672216
Brief Title
Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation
Acronym
3T-CO
Official Title
Triple Target Treatment (3T) Combining Amplitude Modulated Middle Frequency (AM-MF) Stimulation With Electromyography (EMG)EMG-Biofeedback Versus EMG-Biofeedback in Chronic Obstipation
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Unknown status
Study Start Date
August 2012 (undefined)
Primary Completion Date
May 2014 (Anticipated)
Study Completion Date
May 2015 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
dr. schwandner

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Previous studies revealed only a low evidence for the various biofeedback methods and pelvic floor exercises for treatment of chronic obstipation. The number of randomized controlled trials is low with in part significant systemic deficiencies. However, the results from the previous study with 3T treatment in patients with obstructed defecation syndrome (ODS) are so promising that a further randomized controlled trial appears useful to demonstrate a higher degree of evidence. The purpose of this study is to determine whether triple target treatment (3T) or EMG-Biofeedback alone are effective in the treatment of chronic obstipation and if the duration of treatment (3, 6 or 9 months) influence the efficacy.
Detailed Description
Methods in this parallel-group randomized multicenter study with blinded observer we enroll 140 patients with chronic obstipation. The study is divided into two trials. After three months the first trial is completed and can be extended directly into the second trial (completed after 12 months) after an interim analysis. Primary endpoints are changes from baseline to three and twelve months in the Altomare ODS Score.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstipation
Keywords
Exercise Therapy, Biofeedback (Psychology), Adult, Chronic Obstipation/*therapy, EMG - Biofeedback, EMG - Triggered Stimulation, Augmented biofeedback

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Triple Target Treatment
Arm Type
Experimental
Arm Description
In the 3T arm, patients were stimulated with a carrier wave of 25 KHz and biphasic modulations of the pulse train of 40 Hz. Anxious patients trained at first only in the biofeedback mode. The stimulation was introduced after four weeks for these patients. Patients were instructed to carry out the training at home, with an alternating combination in the morning and with EMG-triggered stimulation in the evening, each for 20-minute periods. Apart from this, the protocol of the active treatment group was identical to that of the control group.
Arm Title
EMG-biofeedback alone
Arm Type
Active Comparator
Arm Description
In the biofeedback arm, patients were instructed to carry out EMG-biofeedback training at home, standing, mornings and evenings, for 20-minute periods. The core of the task was to pull the plug-electrode upward inside the anal channel, like a lift, and to hold it there during varying periods of tension. This can only be done successfully if the perineum rises and at the same time the puborectal muscle is activated. Just squeezing the sphincter muscles does not produce this lifting effect.
Intervention Type
Device
Intervention Name(s)
Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation
Intervention Type
Device
Intervention Name(s)
EMG-biofeedback alone
Primary Outcome Measure Information:
Title
Altomare ODS Score in its validated form after 3 and 12 months, compared to baseline.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Constipation severity instrument (CSI) in adapted German form after 3 and 12 months, compared to baseline.
Time Frame
3 and 12 months
Title
Modified Wexner Incontinence Score after 3 and 12 months, compared to baseline
Time Frame
3 and 12 Months
Title
Patient Assessment of Constipation Quality of Life Questionnaire (PAC-QoL) after 3 and 12 months compared to baseline, as well as between the two treatment groups over the course of time as compared to baseline.
Time Frame
3 and 12 months
Title
Hinton Test after 3 and 12 months
Time Frame
3 and 12 months
Title
Cleveland Clinic Incontinence Score (CCS) in its validated German form after 3 and 12 months, compared to baseline
Time Frame
3 and 12 months
Title
Adapted Vaizey score after 3 and 12 months compared to baseline
Time Frame
3 and 12 months
Title
International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) applied to patients with urine incontinence after 3 and 12 months, compared to baseline.
Time Frame
3 and 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All Patients with chronic obstipation (Rom criteria II) Exclusion Criteria: Chronic inflammatory bowel disease, systemic peripheral neuropathy (MS, diabetes), disorders of enteric nervous system (Hirschsprung disease, chagas, IND, myopathy desmosis coli), idiopathic megacolon/megarectum, patients with mental or intellectual deficits.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thilo Schwandner, Dr.
Phone
00496419944701
Email
t.schwandner@web.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thilo Schwandner, Dr.
Organizational Affiliation
University of Giessen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Gießen, Dept. of General Surgery
City
Gießen
State/Province
Hessen
ZIP/Postal Code
35385
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thilo Schwandner, Dr.
Phone
00496419944701
Email
t.schwandner@web.de

12. IPD Sharing Statement

Citations:
PubMed Identifier
21383560
Citation
Schwandner T, Hecker A, Hirschburger M, Hecker M, Kierer W, Padberg W. Does the STARR procedure change the pelvic floor: a preoperative and postoperative study with dynamic pelvic floor MRI. Dis Colon Rectum. 2011 Apr;54(4):412-7. doi: 10.1007/DCR.0b013e318205ddda.
Results Reference
background

Learn more about this trial

Multicenter Randomized Controlled Trial to Compare the Outcome of Conservative Triple Target Treatment With EMG-Biofeedback in Chronic Obstipation

We'll reach out to this number within 24 hrs